FHTX - Foghorn Therapeutics Inc
IEX Last Trade
8.24
0.350 4.248%
Share volume: 106,337
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.89
0.35
4.44%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-09 | 2023-05-08 | 2023-08-04 | 2023-11-02 | 2024-03-07 | 2024-05-06 | |
| Assets | |||||||||
| Total Assets | 456.900 M | 433.932 M | 404.883 M | 372.883 M | 339.576 M | 313.423 M | 285.916 M | 255.004 M | |
| Current Assets | 400.066 M | 377.760 M | 351.399 M | 320.699 M | 290.492 M | 265.442 M | 240.181 M | 211.520 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 5.337 M | 4.237 M | 5.601 M | 4.729 M | 6.181 M | 5.554 M | 6.124 M | 4.859 M | |
| Short Term Investments | 5.337 M | 4.237 M | 5.601 M | 4.729 M | 6.181 M | 5.554 M | 6.124 M | 4.859 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 394.729 M | 373.498 M | 345.798 M | 315.970 M | 284.311 M | 259.888 M | 234.057 M | 206.661 M | |
| Total Non-current Assets | 56.834 M | 56.172 M | 53.484 M | 52.184 M | 49.084 M | 47.981 M | 45.735 M | 43.484 M | |
| Property Plant Equipment | 16.459 M | 15.940 M | 15.311 M | 15.225 M | 14.607 M | 13.793 M | 12.956 M | 12.187 M | |
| Other Assets | 38.642 M | 38.524 M | 36.465 M | 35.251 M | 32.769 M | 32.480 M | 31.071 M | 29.589 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 456.900 M | 433.932 M | 404.883 M | 372.883 M | 339.576 M | 313.423 M | 285.916 M | 255.004 M | |
| Total liabilities | 409.268 M | 409.609 M | 404.771 M | 397.469 M | 388.926 M | 370.811 M | 363.106 M | 352.490 M | |
| Total current liabilities | 47.965 M | 55.210 M | 55.205 M | 55.796 M | 56.637 M | 52.012 M | 58.436 M | 52.065 M | |
| Accounts Payable | 3.635 M | 5.257 M | 5.414 M | 7.288 M | 6.933 M | 6.496 M | 6.260 M | 5.631 M | |
| Other liabilities | 312.160 M | 307.900 M | 304.029 M | 298.180 M | 292.016 M | 280.089 M | 268.115 M | 266.114 M | |
| Current long term debt | 5.669 M | 6.670 M | 5.970 M | 6.346 M | 7.670 M | 8.372 M | 8.518 M | 8.668 M | |
| Long term debt | 49.143 M | 46.499 M | 45.537 M | 43.493 M | 40.273 M | 38.710 M | 36.555 M | 34.311 M | |
| Other liabilities | 312.160 M | 307.900 M | 304.029 M | 298.180 M | 292.016 M | 280.089 M | 268.115 M | 266.114 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 47.632 M | 24.323 M | 112.000 K | -24.586 M | -49.350 M | -57.388 M | -77.190 M | -97.486 M | |
| Common stock | 41.515 M | 41.673 M | 41.808 M | 41.811 M | 41.826 M | 42.026 M | 42.235 M | 42.429 M | |
| Retained earnings | -318.483 M | -344.252 M | -373.138 M | -403.626 M | -433.113 M | -447.458 M | -471.564 M | -496.580 M |